The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Lymphoma, Follicular

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lymphoma, Follicular


High impact information on Lymphoma, Follicular


Chemical compound and disease context of Lymphoma, Follicular


Biological context of Lymphoma, Follicular


Anatomical context of Lymphoma, Follicular


Gene context of Lymphoma, Follicular


Analytical, diagnostic and therapeutic context of Lymphoma, Follicular


  1. Shiga-like toxin purges human lymphoma from bone marrow of severe combined immunodeficient mice. LaCasse, E.C., Saleh, M.T., Patterson, B., Minden, M.D., Gariépy, J. Blood (1996) [Pubmed]
  2. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Egle, A., Harris, A.W., Bath, M.L., O'Reilly, L., Cory, S. Blood (2004) [Pubmed]
  3. FVT-1, a novel human transcription unit affected by variant translocation t(2;18)(p11;q21) of follicular lymphoma. Rimokh, R., Gadoux, M., Berthéas, M.F., Berger, F., Garoscio, M., Deléage, G., Germain, D., Magaud, J.P. Blood (1993) [Pubmed]
  4. Preferential use of the VH4 Ig gene family by diffuse large-cell lymphoma. Hsu, F.J., Levy, R. Blood (1995) [Pubmed]
  5. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines. Delabie, J., Ceuppens, J.L., Vandenberghe, P., de Boer, M., Coorevits, L., De Wolf-Peeters, C. Blood (1993) [Pubmed]
  6. Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte. Solal-Celigny, P., Lepage, E., Brousse, N., Reyes, F., Haioun, C., Leporrier, M., Peuchmaur, M., Bosly, A., Parlier, Y., Brice, P. N. Engl. J. Med. (1993) [Pubmed]
  7. Polymerase chain reaction to confirm extranodal progression of follicular lymphoma. Price, C.G., Cotter, F.E., Curling, O.M., D'Ardenne, A.J., Rohatiner, A.Z., Young, B.D., Lister, T.A. Lancet (1989) [Pubmed]
  8. Molecular insights into the immunopathogenesis of follicular lymphoma. Stamatopoulos, K., Kosmas, C., Belessi, C., Stavroyianni, N., Kyriazopoulos, P., Papadaki, T. Immunol. Today (2000) [Pubmed]
  9. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Elenitoba-Johnson, K.S., Jenson, S.D., Abbott, R.T., Palais, R.A., Bohling, S.D., Lin, Z., Tripp, S., Shami, P.J., Wang, L.Y., Coupland, R.W., Buckstein, R., Perez-Ordonez, B., Perkins, S.L., Dube, I.D., Lim, M.S. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  10. The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma. Callanan, M.B., Le Baccon, P., Mossuz, P., Duley, S., Bastard, C., Hamoudi, R., Dyer, M.J., Klobeck, G., Rimokh, R., Sotto, J.J., Leroux, D. Proc. Natl. Acad. Sci. U.S.A. (2000) [Pubmed]
  11. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Marcus, R., Imrie, K., Belch, A., Cunningham, D., Flores, E., Catalano, J., Solal-Celigny, P., Offner, F., Walewski, J., Raposo, J., Jack, A., Smith, P. Blood (2005) [Pubmed]
  12. Fc gamma RIIIa and Fc gamma RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia. Farag, S.S., Flinn, I.W., Modali, R., Lehman, T.A., Young, D., Byrd, J.C. Blood (2004) [Pubmed]
  13. Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte. Solal-Céligny, P., Brice, P., Brousse, N., Caspard, H., Bastion, Y., Haïoun, C., Bosly, A., Tilly, H., Bordessoule, D., Sebban, C., Harousseau, J.L., Morel, P., Dupas, B., Plassart, F., Vasile, N., Fort, N., Leporrier, M. J. Clin. Oncol. (1996) [Pubmed]
  14. Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. Zinzani, P.L., Pulsoni, A., Perrotti, A., Soverini, S., Zaja, F., De Renzo, A., Storti, S., Lauta, V.M., Guardigni, L., Gentilini, P., Tucci, A., Molinari, A.L., Gobbi, M., Falini, B., Fattori, P.P., Ciccone, F., Alinari, L., Martelli, M., Pileri, S., Tura, S., Baccarani, M. J. Clin. Oncol. (2004) [Pubmed]
  15. Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene. Gauwerky, C.E., Haluska, F.G., Tsujimoto, Y., Nowell, P.C., Croce, C.M. Proc. Natl. Acad. Sci. U.S.A. (1988) [Pubmed]
  16. BCL2 regulates neural differentiation. Zhang, K.Z., Westberg, J.A., Hölttä, E., Andersson, L.C. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  17. Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation. Chen, W., Iida, S., Louie, D.C., Dalla-Favera, R., Chaganti, R.S. Blood (1998) [Pubmed]
  18. Ig VH gene expression among human follicular lymphomas. Bahler, D.W., Campbell, M.J., Hart, S., Miller, R.A., Levy, S., Levy, R. Blood (1991) [Pubmed]
  19. Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasms. Yano, T., Sander, C.A., Andrade, R.E., Gauwerky, C.E., Croce, C.M., Longo, D.L., Jaffe, E.S., Raffeld, M. Blood (1993) [Pubmed]
  20. Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Tsujimoto, Y. Proc. Natl. Acad. Sci. U.S.A. (1989) [Pubmed]
  21. Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. Chleq-Deschamps, C.M., LeBrun, D.P., Huie, P., Besnier, D.P., Warnke, R.A., Sibley, R.K., Cleary, M.L. Blood (1993) [Pubmed]
  22. Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma. Zhao, W.L., Daneshpouy, M.E., Mounier, N., Brière, J., Leboeuf, C., Plassa, L.F., Turpin, E., Cayuela, J.M., Ameisen, J.C., Gisselbrecht, C., Janin, A. Blood (2004) [Pubmed]
  23. Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma. Hosler, G.A., Bash, R.O., Bai, X., Jain, V., Scheuermann, R.H. Am. J. Pathol. (1999) [Pubmed]
  24. Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Gauwerky, C.E., Huebner, K., Isobe, M., Nowell, P.C., Croce, C.M. Proc. Natl. Acad. Sci. U.S.A. (1989) [Pubmed]
  25. Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma. Migliazza, A., Martinotti, S., Chen, W., Fusco, C., Ye, B.H., Knowles, D.M., Offit, K., Chaganti, R.S., Dalla-Favera, R. Proc. Natl. Acad. Sci. U.S.A. (1995) [Pubmed]
  26. Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma. Weng, W.K., Levy, R. Blood (2001) [Pubmed]
  27. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Bourke, E., Bosisio, D., Golay, J., Polentarutti, N., Mantovani, A. Blood (2003) [Pubmed]
  28. Isolation and characterization of cDNA clones corresponding to transcripts from the BamHI H and F regions of the Epstein-Barr virus genome. Pfitzner, A.J., Tsai, E.C., Strominger, J.L., Speck, S.H. J. Virol. (1987) [Pubmed]
  29. High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis. Gopal, A.K., Gooley, T.A., Maloney, D.G., Petersdorf, S.H., Eary, J.F., Rajendran, J.G., Bush, S.A., Durack, L.D., Golden, J., Martin, P.J., Matthews, D.C., Appelbaum, F.R., Bernstein, I.D., Press, O.W. Blood (2003) [Pubmed]
  30. Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma. Leonard, J.P., Coleman, M., Kostakoglu, L., Chadburn, A., Cesarman, E., Furman, R.R., Schuster, M.W., Niesvizky, R., Muss, D., Fiore, J., Kroll, S., Tidmarsh, G., Vallabhajosula, S., Goldsmith, S.J. J. Clin. Oncol. (2005) [Pubmed]
  31. Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial. Solal-Céligny, P., Lepage, E., Brousse, N., Tendler, C.L., Brice, P., Haïoun, C., Gabarre, J., Pignon, B., Tertian, G., Bouabdallah, R., Rossi, J.F., Doyen, C., Coiffier, B. J. Clin. Oncol. (1998) [Pubmed]
  32. bcl-2 and p53 protein expression in follicular lymphoma. Cooper, K., Haffajee, Z. J. Pathol. (1997) [Pubmed]
WikiGenes - Universities